Beiersdorf

Fuelling CARE

17/02/21 -"The higher investments under the umbrella of the already expensive CARE programme have to seen and valued against the back of the current CEO’s predecessor and his targets. This meaningful ..."

PDF page sample
Pages
54
Language
English
Published on
17/02/21
Download
You may also be interested by these reports :
11/12/25
On the back of stronger-than-expected like-for-like sales growth and margin improvement, though partly offset by FX headwinds, our estimates have ...
01/12/25
The earnings decline stems from two main factors: 1. Weak performance in North America, driven by a softer-than-expected US recovery and a ...
10/11/25
The Q3 2025 results came largely as expected, with Adhesive Technologies performing in line, driven by its futuristic solutions. Consumer Brands ...
03/11/25
Puig delivered an impressive Q3 25, beating expectations with extraordinary momentum in makeup and solid progress in Asia. The group raised its FY25 ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO